Goldman Sachs Group Inc Karuna Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

$580 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$161.01 - $317.85 $26.7 Million - $52.8 Million	166,001 Added 470.67%	201,270 $63.7 Million
Q3 2023 May 14, 2024	SELL	$164.66 - $218.08 $27.3 Million - $36.2 Million	-166,001 Reduced 82.48%	35,269 $5.96 Million
Q3 2023 Nov 14, 2023	SELL	$164.66 - $218.08 $9.67 Million - $12.8 Million	-58,735 Reduced 62.48%	35,269 $5.96 Million
Q2 2023 May 14, 2024	SELL	$176.32 - $240.22 $12.7 Million - $17.3 Million	-72,119 Reduced 43.41%	94,004 $20.4 Million
Q2 2023 Aug 14, 2023	SELL	$176.32 - $240.22 $12.7 Million - $17.3 Million	-72,119 Reduced 43.41%	94,004 $20.4 Million
Q1 2023 May 14, 2024	SELL	$161.33 - $204.36 $4.26 Million - $5.4 Million	-26,434 Reduced 13.73%	166,123 $30.2 Million
Q1 2023 May 11, 2023	SELL	$161.33 - $204.36 $4.26 Million - $5.4 Million	-26,434 Reduced 13.73%	166,123 $30.2 Million
Q4 2022 May 14, 2024	BUY	$191.53 - $236.82 $6.95 Million - $8.6 Million	36,311 Added 23.24%	192,557 $37.8 Million
Q4 2022 Feb 13, 2023	BUY	$191.53 - $236.82 $6.95 Million - $8.6 Million	36,311 Added 23.24%	192,557 $37.8 Million
Q3 2022 May 14, 2024	SELL	$123.79 - $277.42 $3.79 Million - $8.5 Million	-30,631 Reduced 16.39%	156,246 $35.1 Million
Q3 2022 Nov 10, 2022	SELL	$123.79 - $277.42 $3.79 Million - $8.5 Million	-30,631 Reduced 16.39%	156,246 $35.1 Million
Q2 2022 May 14, 2024	SELL	$93.97 - $143.33 $1.35 Million - $2.06 Million	-14,393 Reduced 7.15%	186,877 $23.6 Million
Q2 2022 Aug 15, 2022	BUY	$93.97 - $143.33 $3.28 Million - $5.01 Million	34,922 Added 22.98%	186,877 $23.6 Million
Q1 2022 May 16, 2022	BUY	$98.9 - $132.37 $68,438 - $91,600	692 Added 0.46%	151,955 $19.3 Million
Q4 2021 Feb 14, 2022	SELL	$110.64 - $159.4 $70,256 - $101,219	-635 Reduced 0.42%	151,263 $19.8 Million
Q3 2021 Nov 10, 2021	BUY	$101.2 - $125.87 $15.4 Million - $19.1 Million	151,898 New	151,898 $18.6 Million

Others Institutions Holding KRTX

# of Institutions

Shares Held

332K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account